Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Genmab
Pharma
AbbVie, Genmab report ph. 3 survival miss for Epkinly in DLBCL
In the study, Epkinly failed to mount a statistically significant improvement in overall survival, the trial's primary measure.
Eric Sagonowsky
Jan 16, 2026 3:56pm
2025's top biopharma M&A deals
Jan 12, 2026 3:00am
Genmab touts new data that set up Epkinly for FL expansion
Aug 8, 2025 7:25am
Novo, Merck, Hengrui-Elevar—Fierce Pharma Asia
Mar 28, 2025 9:28am
ASH: Roche's subQ Lunsumio matches IV version in lymphoma
Dec 9, 2024 3:16pm
EU signs off on Regeneron's T-cell engager for 2 blood cancers
Aug 26, 2024 10:35am
